• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    55 Biggest Movers From Friday

    4/4/22 4:59:19 AM ET
    $AERC
    $ALLG
    $AUID
    $AVTE
    Environmental Services
    Utilities
    Automotive Aftermarket
    Consumer Discretionary
    Get the next $AERC alert in real time by email

    Gainers

    • Takung Art Co., Ltd. (NASDAQ:TKAT) surged 61.8% to close at $3.64 on Friday.
    • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:CSSE) rose 43.8% to settle at $11.49 on Friday after the company reported Q4 earnings results.
    • Manning & Napier, Inc. (NYSE:MN) shares surged 40.4% to close at $12.79 on Friday after the company reported it will be acquired by Callodine Group and will go private at $12.85 per share.
    • Hudson Capital Inc. (NASDAQ:HUSN) gained 36.3% to settle at $2.63 after the company announced it sold its wholly-owned subsidiary, Hong Kong Internet Financial Services, to private investors.
    • Greenidge Generation Holdings Inc. (NASDAQ:GREE) jumped 34% to close at $11.52 after the company reported Q4 financials results.
    • Weidai Ltd. (NYSE:WEI) jumped 28.8% to close at $1.43 on above-average volume.
    • AeroClean Technologies, Inc. (NASDAQ:AERC) gained 27.2% to close at $4.58. AeroClean Technologies recently posted a Q4 loss of $0.13 per share.
    • Clovis Oncology, Inc. (NASDAQ:CLVS) jumped 23.8% to close at $2.50. Clovis Oncology recently announced positive topline data from the monotherapy arm of Phase 3 ATHENA-MONO trial of Rubraca (Rucaparib) as first-line maintenance treatment in ovarian cancer.
    • ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) rose 23.6% to close at $6.60.
    • Evolve Transition Infrastructure LP (NASDAQ:SNMP) gained 22.6% to close at $0.6389.
    • Leju Holdings Limited (NYSE:LEJU) jumped 21.4% to close at $0.8218. The company, last week, reported FY21 results.
    • HeartCore Enterprises, Inc. (NASDAQ:HTCR) rose 21.2% to close at $3.49.
    • Borr Drilling Limited (NYSE:BORR) jumped 20.9% to close at $4.05.
    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) gained 20.2% to settle at $0.8712.
    • Tellurian Inc. (NYSE:TELL) rose 19.6% to close at $6.34. Credit Suisse upgraded Tellurian from Neutral to Outperform and raised the price target from $5.5 to $8.
    • Blackboxstocks Inc. (NASDAQ:BLBX) shares gained 19.4% to close at $3.20 after the company reported better-than-expected Q4 sales results.
    • Dolphin Entertainment, Inc. (NASDAQ:DLPN) jumped 17.5% to close at $6.12.
    • GreenPower Motor Company Inc. (NASDAQ:GP) surged 16.8% to settle at $8.00. GreenPower Motor, last month, said its purpose-built buses and trucks are eligible for vouchers through the California Air Resources Board (CARB) Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project (HVIP).
    • Fresh Vine Wine, Inc. (NYSE:VINE) surged 16.4% to close at $3.90.
    • Ipsidy Inc. (NASDAQ:AUID) gained 16.1% to close at $4.55.
    • Immuneering Corporation (NASDAQ:IMRX) jumped 15% to close at $7.44. Oppenheimer initiated coverage on Immuneering with an Outperform rating and announced a price target of $25.
    • NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) surged 14.7% to close at $17.50. NGM Bio announced initiation of Phase 1/1b clinical trial of NGM831 for the treatment of patients with advanced solid tumors.
    • Haynes International, Inc. (NASDAQ:HAYN) gained 14.5% to close at $48.80 after KeyBanc maintained an Overweight rating on the stock and raised its price target from $41 to $55.
    • Lulu's Fashion Lounge Holdings, Inc. (NASDAQ:LVLU) gained 14.3% to close at $7.75 following Q4 results.
    • Sigma Lithium Corporation (NASDAQ:SGML) gained 14.3% to close at $15.53.
    • nCino, Inc. (NASDAQ:NCNO) rose 13.7% to close at $46.58 following strong quarterly sales.
    • DiDi Global Inc. (NYSE:DIDI) shares gained 12.8% to close at $2.82. Shares of several Chinese stocks traded higher following reports indicating Chinese authorities are preparing to give U.S. regulators full access to auditing reports of most of the companies listed on American exchanges.
    • Society Pass Incorporated (NASDAQ:SOPA) rose 10.1% to close at $3.27.
    • Dada Nexus Limited (NASDAQ:DADA) gained 9.3% to close at $9.98. Shares of several Chinese stocks traded higher following reports indicating Chinese authorities are preparing to give U.S. regulators full access to auditing reports of most of the companies listed on American exchanges.
    • U.S. Xpress Enterprises, Inc. (NYSE:USX) gained 7.7% to close at $4.18.
    • LSB Industries, Inc. (NYSE:LXU) gained 6.1% to close at $23.17.

     


    Losers

    • SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) shares tumbled 37.9% to close at $4.15 on Friday after the company announced an exclusive license agreement with GenFleet in which the company will pay GenFleet a total of up to $150 million. The company also announced a $25 million common stock offering.
    • Cyren Ltd. (NASDAQ:CYRN) dropped 36% to close at $3.23 on above-average volume.
    • Redwire Corporation (NYSE:RDW) fell 28.7% to settle at $6.05 after the company reported FY21 earnings results and issued FY22 sales guidance.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) fell 27% to close at $3.55 after the company reported worse-than-expected Q4 EPS and sales results.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) shares fell 24.7% to close at $1.43 as the company posted a wider quarterly loss.
    • Shapeways Holdings, Inc. (NASDAQ:SHPW) dipped 21% to close at $2.26. Shapeways Holdings posted a Q4 net loss of $2.4 million.
    • Pineapple Holdings, Inc. (NASDAQ:PEGY) dropped 18.9% to settle at $5.07.
    • Vivos Therapeutics, Inc. (NASDAQ:VVOS) fell 18.7% to settle at $2.18. Vivos Therapeutics posted Q4 sales of $4.40 million.
    • Allego N.V. (NYSE:ALLG) dipped 18.5% to close at $12.32 on below-average volume.
    • Spero Therapeutics, Inc. (NASDAQ:SPRO) fell 18.3% to close at $7.11 after the company reported worse-than-expected Q4 EPS and sales results.
    • Greenbrook TMS Inc. (NASDAQ:GBNH) dipped 17.5% to close at $3.10. Greenbrook TMS posted Q4 loss of $0.34 per share.
    • Reed's, Inc. (NYSE:REED) fell 16.3% to settle at $0.2515 as the company reported fourth-quarter revenue growth of 20% year-over-year to $12.8 million, missing the consensus of $13.02 million.
    • Biophytis SA (NASDAQ:BPTS) dropped 16.2% to close at $2.18.
    • Inspirato Incorporated (NASDAQ:ISPO) dropped 16.1% to close at $8.34 on above-average volume.
    • Blend Labs, Inc. (NYSE:BLND) shares fell 15.8% to close at $4.80 after the company reported worse-than-expected Q4 sales results and issued both Q1 and FY22 sales guidance below analyst estimates.
    • Kidpik Corp. (NASDAQ:PIK) fell 15.6% to close at $4.07 following a wider-than-expected quarterly loss.
    • P.A.M. Transportation Services, Inc. (NASDAQ:PTSI) dipped 14.5% to close at $29.70.
    • Duck Creek Technologies, Inc. (NASDAQ:DCT) dropped 13.9% to close at $19.04 after the company issued Q3 sales guidance below analyst estimates.
    • Aerovate Therapeutics, Inc. (NASDAQ:AVTE) dipped 13.3% to close at $15.90.
    • USA Truck, Inc. (NASDAQ:USAK) fell 13% to close at $17.93.
    • 4D pharma plc (NASDAQ:LBPS) fell 12.8% to close at $4.21 as the company posted a FY21 net loss of $32.1 million.
    • GlucoTrack, Inc. (NASDAQ:GCTK) dipped 12.1% to settle at $3.20.
    • Rail Vision Ltd. (NASDAQ:RVSN) fell 12% to close at $2.72.
    • BlackBerry Limited (NYSE:BB) declined 9.5% to close at $6.75 after the company reportedly announced it expects FY23 cyber security to be flat and expects licensing revenue to be minimal.
    Get the next $AERC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AERC
    $ALLG
    $AUID
    $AVTE

    CompanyDatePrice TargetRatingAnalyst
    Sigma Lithium Corporation
    $SGML
    2/3/2026$14.00Underperform → Neutral
    BofA Securities
    Avalo Therapeutics Inc.
    $AVTX
    2/2/2026$50.00Buy
    Guggenheim
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    Sigma Lithium Corporation
    $SGML
    1/23/2026Hold → Buy
    Canaccord Genuity
    Sigma Lithium Corporation
    $SGML
    1/16/2026Buy → Hold
    Canaccord Genuity
    Sigma Lithium Corporation
    $SGML
    1/8/2026$13.00Neutral → Underperform
    BofA Securities
    Oric Pharmaceuticals Inc.
    $ORIC
    1/7/2026$22.00Overweight
    Piper Sandler
    Redwire Corporation
    $RDW
    12/19/2025Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $AERC
    $ALLG
    $AUID
    $AVTE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sigma Lithium upgraded by BofA Securities with a new price target

    BofA Securities upgraded Sigma Lithium from Underperform to Neutral and set a new price target of $14.00

    2/3/26 6:51:05 AM ET
    $SGML
    Metal Mining
    Basic Materials

    Guggenheim initiated coverage on Avalo Therapeutics with a new price target

    Guggenheim initiated coverage of Avalo Therapeutics with a rating of Buy and set a new price target of $50.00

    2/2/26 6:51:00 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mizuho initiated coverage on Pulse Biosciences with a new price target

    Mizuho initiated coverage of Pulse Biosciences with a rating of Outperform and set a new price target of $25.00

    1/30/26 6:44:12 AM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    $AERC
    $ALLG
    $AUID
    $AVTE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Sainz Maria

    4 - PULSE BIOSCIENCES, INC. (0001625101) (Issuer)

    2/6/26 9:21:10 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Sainz Maria

    3 - PULSE BIOSCIENCES, INC. (0001625101) (Issuer)

    2/6/26 9:18:07 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    EVP, General Counsel and Sec Foster Michael J. was granted 26,545 shares, increasing direct ownership by 8% to 351,575 units (SEC Form 4)

    4 - LSB INDUSTRIES, INC. (0000060714) (Issuer)

    2/6/26 4:30:08 PM ET
    $LXU
    Major Chemicals
    Basic Materials

    $AERC
    $ALLG
    $AUID
    $AVTE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer O'Dowd William Iv bought $4,872 worth of shares (2,900 units at $1.68), increasing direct ownership by 0.68% to 431,690 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/2/26 5:25:10 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer O'Dowd William Iv bought $4,874 worth of shares (2,700 units at $1.80), increasing direct ownership by 0.63% to 428,790 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    1/27/26 4:47:48 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Chief Business Officer Brakewood Harold Eugene bought $24,990 worth of shares (5,250 units at $4.76), increasing direct ownership by 91% to 11,050 units (SEC Form 4)

    4 - Immuneering Corp (0001790340) (Issuer)

    1/21/26 9:09:57 AM ET
    $IMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ALLG
    $AUID
    $AVTE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on February 2, 2026 (the "Grant Date"), ORIC granted a total of 173,800 non-qualified stock options and 28,700 restricted stock units to three new non-executive employees who began their employment with ORIC in January 2026. These inducement grants were granted pursuant to the ORIC Pharmaceuticals, Inc. 2022 Inducement Equity Incentive Plan, subject to recipient's continued employment or service through each applicable vesting date. Th

    2/6/26 4:30:00 PM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Miners Win as China's Export Ban Triggers 54-Nation Pact Reshaping Critical Minerals

    Issued on behalf of GoldHaven Resource Corp. VANCOUVER, BC, Feb. 6, 2026 /PRNewswire/ -- Equity Insider News Commentary — The global supply map just broke. China restricted critical tungsten exports to Japan in January[1], causing the United States to counter by rallying 54 nations and launching $30 billion in strategic financing[2]. This geopolitical chess match is rapidly de-risking domestic production. It position GoldHaven Resources Corp. (CSE:GOH) (OTCQB:GHVNF), Sigma Lithium (NASDAQ:SGML) (TSXV:SGML) , Berkshire Hathaway (NYSE:BRK) (NYSE:BRK), Rio Tinto (NYSE:RIO), and Talon Metals (TSX:TLO) (OTCID: TLOFD) at the forefront of a massive capital rotation. This is a structural pivot, no

    2/6/26 1:00:00 PM ET
    $RIO
    $SGML
    $BRK
    Metal Mining
    Basic Materials

    Rail Vision Advances Strategic Collaboration with Israel Railways Cargo Division

    With its MainLine product already installed on Israel Railways' locomotives, this collaboration aims to expand Rail Vision's product offering by deploying its ShuntingYard product within Israel Railways' cargo division Ra'anana, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (NASDAQ:RVSN) ("Rail Vision" or the "Company"), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, announced today its advancement to the next phase of its collaboration with Israel Railways. As previously announced, Israel Railways purchased and installed Rail Vision's MainLine systems on its locomotives and this advancement marks the

    2/6/26 8:32:00 AM ET
    $RVSN
    Railroads
    Industrials

    $AERC
    $ALLG
    $AUID
    $AVTE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-11) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 06/10/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    6/13/22 2:20:18 PM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ALLG
    $AUID
    $AVTE
    SEC Filings

    View All

    Amendment: SEC Form S-1/A filed by Society Pass Incorporated

    S-1/A - SOCIETY PASS INCORPORATED. (0001817511) (Filer)

    2/6/26 5:26:07 PM ET
    $SOPA
    Real Estate

    Society Pass Incorporated filed SEC Form 8-K: Other Events

    8-K - SOCIETY PASS INCORPORATED. (0001817511) (Filer)

    2/6/26 5:00:27 PM ET
    $SOPA
    Real Estate

    Vivos Therapeutics Inc. filed SEC Form 8-K: Leadership Update

    8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)

    2/6/26 4:05:34 PM ET
    $VVOS
    Medical/Dental Instruments
    Health Care

    $AERC
    $ALLG
    $AUID
    $AVTE
    Leadership Updates

    Live Leadership Updates

    View All

    Lulus Appoints Heidi Crane as Permanent Chief Financial Officer

    CHICO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Lulu's Fashion Lounge Holdings, Inc. ("Lulus" or the "Company") (NASDAQ:LVLU) today announced the appointment of Heidi Crane as its permanent Chief Financial Officer ("CFO"), effective February 4, 2026. Ms. Crane previously served as the Company's fractional CFO since October 13, 2025. "We're thrilled to have Heidi officially join our team as permanent CFO," said Crystal Landsem, CEO of Lulus. "After working closely with us in a fractional capacity, Heidi has demonstrated exceptional financial discipline, strategic insight, and a deep understanding of our business. Heidi's transition to Lulus' permanent CFO was a natural next step, and we'r

    2/5/26 4:03:00 PM ET
    $LVLU
    Catalog/Specialty Distribution
    Consumer Discretionary

    Melissa Xides Appointed Exclusive Resorts President

    Former Bergdorf Goodman executive joins to strengthen a more private, relationship-led Club for a discerning global Membership Exclusive Resorts today announced the appointment of Melissa Xides as President, signaling a new chapter for the Members-only luxury club following a sustained period of growth and the recent launch of The Exclusive Collective, uniting three market-leading brands to form one of the most expansive private networks in luxury hospitality. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260113869302/en/Melissa Xides, President - Exclusive Resorts After more than six years of expansion across the Club's $1 b

    1/13/26 8:00:00 AM ET
    $ISPO
    Blank Checks
    Finance

    ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones

    Announced rinzimetostat (ORIC-944) Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds and initiated dose optimization in combination with AR inhibitors Presented potential best-in-class enozertinib Phase 1b data demonstrating highly competitive systemic and intracranial activity in NSCLC patients with EGFR exon 20 and EGFR PACC mutations; selected Phase 3 monotherapy dose Raised $244 million from top-tier healthcare specialist funds; Cash and investments of $413 million expected to provide runway into 2H 2028 and beyond anticipated primary endpoint readout for rinzimetostat Phase 3 study Expect to report multiple cli

    1/12/26 8:30:00 AM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ALLG
    $AUID
    $AVTE
    Financials

    Live finance-specific insights

    View All

    Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026

    Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced it will report business updates and financial results for the fourth quarter and full year 2025 after market close on Thursday, February 19, 2026. Company management will host a corresponding conference call beginning at 1:30pm PT / 4:30pm ET. Investors interested in listening to the conference call may do so by dialing 1-800-715-9871 from the U.S. or 1-646-307-1963 internationally and providing Conference ID 7647402. A live and recorded webcast of the event will be available on the Pulse Bioscie

    2/4/26 4:05:00 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    Borr Drilling Limited - Invitation to Webcast and Conference Call for Q4 2025 Results

    HAMILTON, Bermuda, Jan. 30, 2026 /PRNewswire/ -- Borr Drilling Limited (NYSE and Euronext Growth Oslo: BORR) (the "Company") plans to release its financial results for the fourth quarter of 2025 after the close of the New York Stock Exchange on Wednesday, February 18, 2026. A conference call and webcast are scheduled for 09:00 New York time (15:00 CET) on Thursday, February 19, 2026. The earnings report, webcast and accompanying presentation will be available on the Investor Relations section of the Company's website, www.borrdrilling.com. In order to listen to the live presentation, participants may do one of the following: a)    Webcast To access the webcast, please go to the following l

    1/30/26 10:09:00 AM ET
    $BORR
    Oil & Gas Production
    Energy

    GreenPower Announces Issuance of Convertible Debentures and Series B Convertible Preferred Shares

    Not for Distribution to United States News Wire Services or for Dissemination in the United States VANCOUVER, BC, Jan. 29, 2026 /CNW/ -- GreenPower Motor Company Inc. (NASDAQ:GP) ("GreenPower" or the "Company"), a leading manufacturer and distributor of all-electric, purpose-built, zero-emission medium and heavy-duty vehicles serving the cargo and delivery market, shuttle and transit space and school bus sector, today announces that it has converted (the "Debenture Offering") US$7,000,000 of principal and accrued interest of outstanding loans with certain related parties of the Company into convertible debentures of the Company (each, a "Debenture").

    1/29/26 12:00:00 PM ET
    $GP
    Construction/Ag Equipment/Trucks
    Consumer Discretionary

    $AERC
    $ALLG
    $AUID
    $AVTE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by nCino Inc.

    SC 13D/A - nCino, Inc. (0001902733) (Subject)

    12/12/24 6:29:06 PM ET
    $NCNO
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/6/24 4:30:32 PM ET
    $REED

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/4/24 6:11:30 AM ET
    $REED

    $AERC
    $ALLG
    $AUID
    $AVTE
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Led to the Purchase at Aerovate Therapeutics Inc. on Jun 20?

    Recently, on June 20, 2024, a notable insider purchase was made at Aerovate Therapeutics Inc. Director Ra Capital Management, L.P. bought $1,549,944 worth of shares, acquiring 928,110 units at $1.67 per share as reported in the SEC Form 4. Insider transactions like these are closely watched by investors as they can provide valuable insights into the company's prospects. When analyzing insider transactions, it is essential to look for patterns and trends among multiple transactions to gauge the overall sentiment within the company. Several other SEC Form 4 filings were made around the same time, on June 7, 2024, by various insiders at Aerovate Therapeutics Inc. These included transactions by

    6/21/24 3:23:59 PM ET
    $AVTE
    Biotechnology: Pharmaceutical Preparations
    Health Care